US Executive Compensation Proxy SEC Filings — April 10, 2026

10-04-2026

Riley Exploration Permian, Inc. issued its 2026 Proxy Statement for the virtual Annual Meeting on May 12, 2026, seeking approval for electing seven directors, ratifying BDO USA, P.C. as auditors, advisory vote on executive compensation, and amending the 2021 Long Term Incentive Plan. In 2025, the company completed the Silverback acquisition and other deals, increasing net undeveloped locations by nearly 50% from year-end 2024; sold its midstream interest for a $72M pre-tax gain, reducing debt by $120M (32%); and grew shareholders' equity by $5.46 per share (22%), while raising the dividend 5% and authorizing a $100M share repurchase program. No declines or flat metrics were reported.

• ·2026 Annual Meeting scheduled for May 12, 2026, at 9:00 a.m. Central Time via virtual webcast.
• ·Silverback acquisition completed in July 2025.

10-04-2026

Plains GP Holdings LP (PAGP) has issued a proxy statement for its Annual Meeting on May 20, 2026, at 10:30 a.m. CT in Houston, TX, with a record date of March 23, 2026. Shareholders will vote on electing four Class I directors (Willie Chiang, Ellen DeSanctis, Alexandra Pruner, and Lawrence Ziemba) to serve until the 2029 annual meeting, ratifying PricewaterhouseCoopers LLP as auditors for the fiscal year ending December 31, 2026, and approving on a non-binding basis the 2025 named executive officer compensation. As of the record date, there were 197,904,124 Class A shares, 35,096,306 Class B shares, and 530,943,161 Class C shares outstanding, with all Class C shares owned by Plains All American Pipeline, L.P. (PAA) for pass-through voting.

• ·PAGP Annual Meeting voting deadline: 11:59 p.m. ET on May 19, 2026 (Internet/telephone); legal proxy registration deadline: 5:00 p.m. ET on May 13, 2026.
• ·PAA Annual Meeting held immediately prior to PAGP meeting for pass-through voting instructions on Class C shares (excluding Plains AAP).
• ·Broker non-votes possible for non-routine Proposals 1 and 3 (director election and advisory compensation vote); only Proposal 2 (auditor ratification) is routine.

10-04-2026

Plains All American Pipeline LP (PAA) has issued a proxy statement for its Annual Meeting on May 20, 2026, at 10:00 a.m. CT in Houston, TX, soliciting votes from unitholders of record as of March 23, 2026 (705,531,683 common units and 58,411,908 Series A preferred units outstanding). Unitholders will vote on electing four Class I directors (Willie Chiang, Ellen DeSanctis, Alexandra Pruner, Lawrence Ziemba) to serve until 2029, ratifying PricewaterhouseCoopers LLP as auditor for FY 2026, and advisory approval of 2025 executive compensation; the PAGP Annual Meeting follows with pass-through voting via 530,943,161 Class C shares.

• ·Voting deadline: Internet/telephone until 11:59 p.m. ET on May 19, 2026; legal proxy registration by 5:00 p.m. ET on May 13, 2026.
• ·Meeting location: Texas Room, 19th Floor, Three Allen Center, 333 Clay Street, Houston, Texas 77002.
• ·Proxy materials and 2025 Annual Report available electronically from April 10, 2026; requests to Investor Relations at plainsIR@plains.com.

10-04-2026

Comstock Inc. (LODE) issued a DEF 14A proxy statement dated April 10, 2026, for its annual shareholder meeting at the Peppermill Hotel in Reno, NV, with a record date of March 31, 2026, when 74,099,140 shares of common stock were outstanding. Shareholders will vote on electing eight director nominees, ratifying Assure CPA, LLC as the independent auditor for FY 2026, approving a non-binding advisory resolution on named executive officer compensation, and approving the Comstock Inc. 2026 Equity Incentive Plan. The Board recommends voting 'FOR' all proposals, with a quorum requiring one-third of outstanding shares.

• ·Quorum requires one-third of outstanding shares present in person or by proxy.
• ·Proxy submission deadline: 5:00 p.m., PDT, on May 27, 2026.
• ·Election of directors by plurality vote; other proposals require votes in favor to exceed votes against.

10-04-2026

Republic Airways Holdings Inc. (RJET), following its merger with Mesa Air Group on November 25, 2025, is holding its Annual Meeting of Stockholders on May 21, 2026, with a record date of March 27, 2026, and 46,829,476 shares of Common Stock outstanding. Stockholders will vote on Proposal No. 1: election of six director nominees (Ellen N. Artist, David Grizzle, Michael C. Lenz, Ruth Okediji, Barry W. Ridings, and James E. Sweetnam); Proposal No. 2: non-binding advisory vote on executive compensation; and Proposal No. 3: ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2026, noting a recent change in auditor. The Board recommends voting 'FOR' all proposals.

• ·Proxy voting deadline for record stockholders: 11:59 p.m. Eastern Time on May 20, 2026.
• ·Merger consummated on November 25, 2025; stock began trading as RJET on Nasdaq Global Select Market same day.
• ·Fiscal year changed to end December 31, effective January 1, 2025.
• ·Proposals 1 and 2 are non-routine (broker non-votes possible); Proposal 3 is routine.

10-04-2026

Quanta Services, Inc.'s DEF 14A proxy statement outlines corporate governance practices, including the roles and responsibilities of the Chairman of the Board and Lead Director, the Board's active oversight of strategy through reviews of the five-year strategic plan focusing on workforce, growth, margins, and capital allocation, and enterprise-wide risk management led by key executives. The Board and its committees, such as Audit, Compensation, Finance and Investment, and Governance and Nominating, oversee specific risks including financial reporting, compensation, acquisitions, and governance structure. No financial performance metrics or period-over-period comparisons are disclosed in this governance-focused filing.

10-04-2026

Vontier Corporation (VNT) filed its DEF 14A Proxy Statement on April 10, 2026, for the 2026 Annual Meeting of Stockholders on June 4, 2026, at 12:30 p.m. ET via live webcast, with a record date of April 6, 2026. Shareholders will vote on electing eight director nominees (Karen C. Francis, Gloria R. Boyland, Maryrose Sylvester, Robert L. Eatroff, David M. Foulkes, Mark D. Morelli, and J. Darrell Thomas), ratifying Ernst & Young LLP as independent auditors for the year ending December 31, 2026, and approving named executive officer compensation on an advisory basis. The filing includes disclosures on corporate governance, director compensation, and executive pay versus performance, but no specific financial performance metrics or period-over-period changes are detailed in the provided content.

• ·Annual Meeting held online only via live webcast at www.virtualshareholdermeeting.com/VNT2026.
• ·Voting methods include Internet, telephone, or traditional proxy card.
• ·Board recommends FOR all three proposals.

10-04-2026

Honeywell's 2026 DEF 14A proxy statement details significant 2025 progress on its separation into three public companies: Honeywell (automation-focused), Honeywell Aerospace, and Solstice Advanced Materials, which completed its spin-off on October 30, 2025, and trades as SOLS on Nasdaq. Leadership for post-separation entities includes Vimal Kapur as Chairman and CEO of core Honeywell, Jim Currier as President and CEO of Honeywell Aerospace (with separation expected in Q3 2026), and Craig Arnold as independent Chairman of Honeywell Aerospace's Board. The Board welcomed Indra K. Nooyi (effective January 1, 2026) and Marc Steinberg (effective May 31, 2025), with Michael W. Lamach succeeding William S. Ayer as independent Lead Director post-annual meeting.

• ·Solstice Advanced Materials began trading on Nasdaq under ticker 'SOLS' on October 30, 2025.
• ·Indra K. Nooyi joined Board on January 1, 2026.
• ·Marc Steinberg joined Board on May 31, 2025.
• ·Aerospace Technologies and Automation businesses separation expected in Q3 2026.

10-04-2026

Montauk Renewables, Inc. (MNTK) has issued its 2026 Proxy Statement for the virtual Annual Meeting on May 26, 2026 (record date April 2, 2026), seeking shareholder approval to elect two Class III directors—Jennifer Cunningham (independent) and Sean McClain (President and CEO)—for terms expiring in 2029, and to ratify Grant Thornton LLP as independent auditor for the year ending December 31, 2026. The Board consists of six members in a classified structure transitioning to annual elections starting in 2030. As of the record date, 143,243,304 shares of common stock were outstanding, listed on Nasdaq (MNTK) and JSE (MKR).

• ·Company qualifies as Emerging Growth Company (EGC) under JOBS Act; scaled disclosures applied; EGC status ends in 2027, leading to enhanced compensation disclosures and advisory votes thereafter.
• ·Annual Meeting held virtually at www.virtualshareholdermeeting.com/MNTK2026.
• ·Directors elected by plurality vote; majority against policy requires resignation consideration for uncontested nominees.
• ·Class I directors (Ahmed, Copelyn) terms expire 2027; Class II (Govender, Shaik) expire 2028.

10-04-2026

M/I Homes, Inc. (MHO) filed a DEF 14A proxy statement dated April 10, 2026, for its virtual-only 2026 Annual Meeting of Shareholders on May 13, 2026, at 9:00 a.m. EDT. Key proposals include electing three directors to serve until the 2029 Annual Meeting, an advisory vote to approve named executive officer compensation, and ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2026. There were 25,590,109 common shares outstanding as of the record date, March 16, 2026.

• ·Annual Meeting accessible virtually at www.meetnow.global/MNUWY4Y
• ·Street name shareholders must request control number by 5:00 p.m. EDT on May 8, 2026, via legalproxy@computershare.com
• ·Proxy voting deadline via Internet/telephone: 1:00 a.m. EDT on May 13, 2026

10-04-2026

Welltower Inc.'s 2026 Proxy Statement summarizes robust 2025 performance, including $937 million net income attributable to common stockholders, 14.1% year-over-year same store NOI growth (21.5% in seniors housing operating portfolio), and $11 billion in pro rata net investments. The company created approximately $100 billion in shareholder value from 2021-2025 with 228.2% cumulative TSR (49.9% in 2025), launched Welltower 3.0 and the Seniors Housing Fund I LP with $2.5 billion equity commitments, and increased the quarterly dividend by 10.4%. No material declines or flat performance were reported across highlighted metrics.

• ·Net Debt to Adjusted EBITDA of 3.03x as of 2025
• ·Credit ratings upgraded to A- (S&P) and A3 (Moody’s) with stable outlooks
• ·Achieved GRESB Green Star status for fifth consecutive year (29/30 points in Management)
• ·#1 ranking from Green Street Advisors for Corporate Governance amongst US REITs
• ·Market cap comprises 9.7% of MSCI US REIT Index as of Oct 5, 2025 (10.8% as of Dec 31, 2025)

10-04-2026

TransMedics Group, Inc. (TMDX) filed its DEF 14A Proxy Statement on April 10, 2026, for the virtual 2026 Annual Meeting on May 20, 2026, proposing the election of 8 directors, an advisory vote on executive compensation, an amendment to the 2019 Stock Incentive Plan to increase authorized shares by 2,750,000, and ratification of PricewaterhouseCoopers LLP as auditors for FY 2026. As of the March 25, 2026 record date, 34,532,341 shares of common stock (including 4,213 restricted shares) were outstanding, held by approximately 26 registered shareholders. No financial performance metrics, period-over-period comparisons, or compensation amounts are numerically detailed in the filing content.

• ·Annual Meeting: May 20, 2026 at 8:00 A.M. ET, virtual at www.virtualshareholdermeeting.com/TMDX2026
• ·Record date: close of business March 25, 2026
• ·Voting instructions deadline: 11:59 P.M. ET on May 19, 2026 via internet, phone, or mail
• ·XBRL tags reference compensation elements for PEO and Non-PEO NEOs across 2021-2025 but no specific values provided

10-04-2026

NorthEast Community Bancorp, Inc. has filed a definitive proxy statement for its 2026 annual meeting of stockholders, to be held virtually on May 21, 2026 at 9:00 a.m. ET via https://www.cstproxy.com/necb/2026. Shareholders as of the April 2, 2026 record date, when 13,815,407 shares of common stock were outstanding, will vote on electing four directors for three-year terms by plurality, approving the 2026 Equity Incentive Plan by majority of votes cast, and ratifying S.R. Snodgrass, P.C. as independent auditors for the fiscal year ending December 31, 2026. The Board recommends voting 'FOR' all proposals; no financial performance metrics or period comparisons are discussed.

• ·Voting restrictions: Record holders beneficially owning >10% of shares generally cannot vote excess shares unless approved by majority of disinterested directors.
• ·Quorum: Majority of outstanding shares; abstentions and broker non-votes count for quorum but not votes cast (except directors elected by plurality).
• ·ESOP/401(k) participants direct voting for allocated shares; unallocated/ESOP unvoted shares follow ESOP Committee (outside directors).

10-04-2026

Masco Corporation's 2026 Proxy Statement details the CEO transition from Keith Allman to Jonathon Nudi in 2025, alongside updates to the executive compensation program shifting annual RSU grants to forward-looking time-based awards to better align with shareholder value. In 2025, the company generated solid profitability despite a challenging macroeconomic environment that negatively impacted sales and operating margins. The filing includes proposals for director elections, advisory vote on executive compensation, auditor ratification, charter amendments, and a stockholder proposal on special meetings, following engagement with shareholders representing 45% of outstanding shares.

• ·Proposals include: (1) Election of director nominees, (2) Advisory vote on named executive officer compensation, (3) Ratification of PricewaterhouseCoopers LLP as independent auditors, (4-6) Charter amendments on officer liability, advance notice provisions, and special meetings, (7) Stockholder proposal for shareholder right to call special meetings.
• ·Board features balanced director tenure for fresh perspectives and industry knowledge.
• ·Compensation program highlights: long-term equity incentives, clawback provisions, stock ownership requirements, double-trigger change-in-control, no hedging/pledging, no employment agreements.

10-04-2026

Hecla Mining Company's 2026 Proxy Statement summarizes strong 2025 performance with record revenue over $1.4 billion (+53% YoY), gross profit of $622 million (three-fold increase), net income of $321 million ($0.49 per share), silver production of 17 million ounces (+5% YoY), and gold production of 151 thousand ounces (+6% YoY), alongside substantial deleveraging to $276 million total debt (-50% YoY). The Board recommends voting for two Class I director nominees, ratification of BDO USA, P.C. as 2026 auditors, advisory approval of 2025 NEO compensation, and extension of the Nonemployee Directors Stock Plan to 2036. Board composition features 43% women directors, 14% racial/ethnic diversity, and 71% refreshment since 2021 with average tenure of 5.7 years.

• ·Proposals: Elect two Class I directors; Ratify BDO USA, P.C. for 2026; Advisory vote on 2025 NEO compensation; Amend Nonemployee Directors Stock Plan to extend termination to May 15, 2036.
• ·All operations generated positive free cash flow in 2025.
• ·Added to S&P MidCap 400 Index.
• ·Keno Hill achieved first year of profitability and positive free cash flow under Hecla ownership.
• ·Engaged with 36 largest shareholders representing 306.6 million shares in Q1 2026.
• ·Average board age 63 years; 6 of 7 directors independent.

10-04-2026

Voya Financial's 2026 Proxy Statement highlights exceptional 2025 performance, exceeding financial targets with over $1 billion in pre-tax adjusted operating earnings, $775 million in excess capital generation, and 22% adjusted EPS growth across all business segments. Key achievements include Retirement reaching 10 million participants with record $28.2 billion organic DC net flows and $959 million adjusted operating earnings near 40% margins, Employee Benefits improving from $40 million to $152 million in adjusted operating earnings, and Voya Investment Management achieving record $14.6 billion net flows with net revenues over $1 billion. NEO annual cash incentives were paid at 178% to 209% of target, reflecting strong individual contributions amid assets under management/administration surpassing $1 trillion.

• ·OneAmerica integration delivered adjusted operating earnings well in excess of $75M target
• ·Voya Investment Management adjusted operating margin held at 28.3%
• ·Excess capital generation 10% above targets supporting $374M capital return to shareholders
• ·Secured DALBAR’s Excellent designation for 15th consecutive year and PLANADVISER Adviser Choice Award
• ·100% resolution of critical cybersecurity vulnerabilities within SLAs
• ·Target annual cash incentives: Ms. Lavallee $2.5M, Mr. Katz $1.625M, Mr. Kaduson $1.875M, Mr. Toms $2.1125M, Mr. Keshavan $1.35M

10-04-2026

Bruker Corporation issued its DEF 14A Proxy Statement for the 2026 Annual Meeting of Stockholders, to be held virtually on May 21, 2026, at 10:00 a.m. ET. Key proposals include electing director nominees for terms expiring at the 2029 Annual Meeting, an advisory vote to approve 2025 named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as independent auditors for fiscal 2026. The record date is April 1, 2026, with proxy materials available online.

• ·Virtual meeting only at www.virtualshareholdermeeting.com/BRKR2026
• ·Proxy materials and 2025 Form 10-K available at https://ir.bruker.com/financial-info/annual-meeting-materials/
• ·Stockholder list available for examination 10 days prior to meeting at 40 Manning Road, Billerica, MA 01821

10-04-2026

Garrett Motion Inc. (GTX) has issued its DEF 14A proxy statement for the 2026 Annual Meeting of Shareholders on May 28, 2026, at 8:30 a.m. ET via virtual webcast, with a record date of April 2, 2026; shareholders will vote on electing eight directors, ratifying Deloitte SA as independent auditors for FY 2026, and advisory approval of named executive officer compensation. The company highlighted strong 2025 full-year performance with Net Sales of $3.58 billion, Net Income of $310 million (8.6% margin), Adjusted EBIT of $510 million (14.2% margin), Net Cash Provided by Operating Activities of $413 million, and Adjusted Free Cash Flow of $403 million. Capital returns included $208 million in common stock repurchases (reducing share count by more than 40% since 2023), initiation and increase of quarterly dividends to $0.08 per share, $50 million term loan repayment, and a new $250 million share repurchase program for 2026.

• ·2026 Annual Meeting is virtual only via www.virtualshareholdermeeting.com/GTX2026.
• ·Record date: April 2, 2026.
• ·Initial quarterly dividend: $0.06 per share, increased to $0.08 per share in Q4 2025.
• ·Proxy materials and 2025 Annual Report available at proxyvote.com and investors.garrettmotion.com.

10-04-2026

The proxy statement seeks ratification of KPMG LLP as the independent auditor for 2026, with audit fees increasing 12.4% YoY to $1,180,000 in 2025 from $1,050,317 in 2024, and total fees rising 69.5% to $1,779,800 due to $599,800 in new tax fees. The Board consists of 7 members (5 independent), held 4 meetings in 2025 with full attendance, and non-management directors received $20,000 cash plus $120,097 in RSUs. No annual stockholder meeting was held in 2025 due to lack of quorum.

• ·Audit committee consists of Constantino (chair), Kavanaugh, Laffer, Swain, and Wood; all financially literate and independent.
• ·Non-management directors each received additional chair/lead fees: Audit chair $15,000, Compensation/Nominating chairs $7,500 each, Lead independent $10,000.
• ·No annual stockholder meeting held in 2025 due to lack of quorum.
• ·Adviser has right to designate 2 board nominees (Dondero and Mitts).

10-04-2026

Northern Oil and Gas, Inc. has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders, to be held virtually on May 21, 2026, at 1:00 p.m. Central Time via www.virtualshareholdermeeting.com/NOG2026. The meeting agenda includes electing seven directors to serve until the 2027 annual meeting, ratifying Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and an advisory vote to approve compensation of named executive officers. The record date is March 26, 2026, with 105,777,359 shares of common stock outstanding held by approximately 131 holders of record.

• ·Proposals 1 (election of directors) and 3 (advisory vote on executive compensation) are non-routine matters under NYSE rules, precluding broker discretionary voting; Proposal 2 (auditor ratification) is routine.
• ·A majority of shares entitled to vote is required for quorum.
• ·Proxy materials and 2025 Form 10-K available at www.noginc.com/investor-relations/financials/annual-reports.

10-04-2026

Hope Bancorp, Inc. (HOPE) filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders on May 21, 2026, proposing the election of 9 directors (7 current and 2 new nominees), ratification of Crowe LLP as independent auditor for 2026, and an advisory vote to approve 2025 Named Executive Officer compensation. The shareholder letter highlights 2025 progress including the acquisition of Territorial Bancorp in April 2025 to enter the Hawaii market, lowered deposit costs, reduced brokered funding reliance, improved asset quality and earning asset mix, talent investments, and governance enhancements such as strengthened Lead Independent Director role and majority voting for directors. Board size will reduce to 9 following the meeting, with no declines or flat metrics reported.

• ·Annual Meeting: Thursday, May 21, 2026 at 10:30 AM Pacific Time, virtual at www.meetnow.global/HOPE2026.
• ·Record Date: Close of business on March 23, 2026.
• ·2025 Annual Report on Form 10-K and Proxy Statement available at www.envisionreports.com/HOPE.

10-04-2026

HealthStream, Inc. (HSTM) filed its DEF 14A proxy statement on April 10, 2026, for its upcoming annual meeting, proposing the re-election of three Class II directors—A. Alex Jahangir, M.D., Jeffrey L. McLaren, and Linda Rebrovick—for terms expiring in 2029, maintaining a nine-member Board that includes newly appointed director Charles E. Beard, Jr. (March 7, 2025). The filing details corporate governance practices, director qualifications, and shareholder proposal deadlines, including December 11, 2026, for Rule 14a-8 inclusion in the next proxy and February 27, 2027, for other 2027 Annual Meeting nominations. No financial performance metrics or period-over-period comparisons are provided.

• ·Charles E. Beard, Jr. appointed to Board on March 7, 2025, as disclosed in Form 8-K filed March 11, 2025.
• ·Universal proxy rule notice for alternative director nominees due no later than March 29, 2027.
• ·Nominations for 2027 Annual Meeting must be received no earlier than January 28, 2027.

10-04-2026

Bausch & Lomb Corp (BLCO) filed its 2026 DEF 14A Proxy Statement on April 10, 2026, nominating eight independent directors for election: Eduardo Alfonso, M.D., Nathalie Bernier, Steven H. Collis, Sarah B. Kavanagh, Karen L. Ling, John A. Paulson, Russel C. Robertson, and Thomas W. Ross, Sr. New directors Dr. Alfonso and Mr. Collis were appointed effective January 1, 2026, filling vacancies from resignations of Messrs. Icahn (December 17, 2025) and Hu (August 18, 2025); none are related to each other or executives. Director share ownership varies, with some meeting the 5x annual retainer target (e.g., 2.1x for Paulson and Robertson) and others in progress (e.g., 0.2x for Alfonso).

• ·All directors attended 100% of 2025 Board meetings where applicable (8/8), except Mr. Robertson's Audit and Risk Committee (7/8).
• ·Share ownership guideline target is 5x the $400,000 annual Board cash retainer; met by Bernier (2x), Kavanagh (1.3x), Paulson (2.1x), Robertson (2.1x); in progress for Alfonso (0.2x), Collis (0.6x), Ling (0.8x).
• ·Document originally filed with SEC and SEDAR+ on February 28, 2024.

10-04-2026

Clene Inc. has issued a proxy statement for its 2026 Annual Meeting of Stockholders on May 21, 2026, at 11:00 a.m. MDT in Salt Lake City, Utah, seeking approval for electing directors Robert Etherington, Shalom Jacobovitz, and Alison H. Mosca; ratifying Deloitte as independent auditor for FY 2026; advisory approval of NEO compensation; and amending the Amended 2020 Stock Plan to increase reserved common shares by 1,000,000. The record date is March 25, 2026, with 11,778,307 shares of common stock outstanding. The Board recommends voting 'FOR' all four proposals.

• ·Annual Meeting voting deadline: proxies via telephone/Internet by 11:59 p.m. EDT on May 20, 2026; mail prior to meeting start.
• ·Quorum requires majority of 11,778,307 shares present or by proxy.
• ·Proposal 1 (director election) uses plurality vote; Proposals 2-4 require majority of votes cast; broker non-votes have no effect.

10-04-2026

VeriSign's 2025 business highlights show revenue of $1.66 billion, up 6.4% from 2024, operating income of $1.12 billion, up 5.9%, .com and .net domain name base of 173.5 million, up 2.6% from December 31, 2024, and 41.7 million new domain name registrations processed, up 11.5% from 2024. The 2026 proxy statement proposes election of seven directors, advisory vote on executive compensation, amendment and restatement of the 2006 Equity Incentive Plan, ratification of KPMG LLP as auditors (all board-recommended FOR), and a stockholder proposal for an independent chair policy (board-recommended AGAINST).

• ·2026 Annual Meeting: May 21, 2026 at 10:00 a.m. Eastern Time, 12061 Bluemont Way, Reston, Virginia 20190
• ·Record date: April 1, 2026
• ·Seven director nominees for election

10-04-2026

Palomar Holdings, Inc. (PLMR) filed its DEF 14A proxy statement for the 2026 Annual Meeting of Stockholders on May 21, 2026, seeking approval for the election of two Class I directors (Daryl Bradley and Thomas Bradley), an advisory vote on named executive officer compensation (Say-on-Pay), and ratification of the independent registered public accounting firm. The Board consists of seven members, 86% independent with an average age of 60.4 and tenure of 5.4 years, and is in the process of declassifying beginning with the 2027 Annual Meeting. No financial performance declines or flat metrics are detailed in the proxy.

• ·Annual Meeting at 9:00 a.m. Pacific Time on May 21, 2026, at 7979 Ivanhoe Avenue, Suite 500, La Jolla, CA 92037.
• ·Board declassification phased-in starting 2027 Annual Meeting.
• ·Committees: Audit, Compensation, Nominating and Corporate Governance, Sustainability, Enterprise Risk Management, Investment.

10-04-2026

Solana Company has filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Stockholders, scheduled virtually on May 21, 2026, at 9:00 a.m. ET, to elect seven directors for one-year terms and ratify CBIZ CPAs P.C. as independent auditors for the year ending December 31, 2026. The Board unanimously recommends voting FOR all proposals, with the record date set as April 1, 2026. No financial performance metrics or changes are highlighted in the filing.

• ·Record date: April 1, 2026
• ·Meeting format: completely virtual via www.virtualshareholdermeeting.com/HSDT2026
• ·Proxy materials available at www.proxyvote.com

10-04-2026

Beta Bionics, Inc. (BBNX) has issued a definitive proxy statement for its 2026 Annual Meeting of Stockholders, to be held virtually on May 21, 2026 at 2:00 P.M. Pacific Time via www.virtualshareholdermeeting.com/BBNX2026. The meeting includes Proposal 1 to elect two Class I directors to serve until the 2029 Annual Meeting and Proposal 2 to ratify Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date for stockholder voting eligibility is March 23, 2026.

• ·Proxy materials available at https://investors.betabionics.com/financials/sec-filings.
• ·Stockholders of record as of March 23, 2026, or their proxy holders, may attend and vote online using a 16-digit control number.
• ·Online check-in begins at 1:45 P.M. Pacific Time on May 21, 2026.

10-04-2026

Establishment Labs Holdings Inc. (ESTA) filed its DEF 14A proxy statement on April 10, 2026, for the 2026 Annual Meeting of Shareholders to be held virtually on May 22, 2026, at 1:00 pm Eastern Time. Shareholders of record as of April 2, 2026, will vote on electing six director nominees, advisory approval of named executive officer compensation, and ratification of CBIZ CPAs P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Meeting accessible via www.virtualshareholdermeeting.com/ESTA2026.
• ·Board recommends voting FOR all three proposals.
• ·Proxy materials available at www.proxyvote.com and www.establishmentlabs.com.

10-04-2026

TPG Twin Brook Capital Income Fund issued a proxy statement for its 2026 Annual Meeting of Shareholders on May 28, 2026, at 9:00 a.m. Central Time in Chicago, to elect one Class I Trustee for a three-year term expiring in 2029 and ratify Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date is March 31, 2026, with 102,324,253 common shares outstanding, and the Board unanimously recommends voting 'FOR' both proposals. No other matters are anticipated.

• ·Shareholders must pre-register by emailing tcap@tpg.com by 5:00 p.m. ET on May 27, 2026 to attend in person at 111 South Wacker Drive, Chicago, IL 60606.
• ·Proxy materials available at www.voteproxy.com, www.sec.gov, www.AGTBCAP.com, and http://www.astproxyportal.com/ast/98390.
• ·Proxies must be submitted by 11:59 p.m. CT on May 27, 2026.

10-04-2026

Avalo Therapeutics' DEF 14A proxy statement for the June 2, 2026 virtual Annual Meeting (record date April 6, 2026) affirms board independence for directors including Mr. Heffernan, Mr. Chan, Dr. Goldman, Dr. Jain, Mr. Kantoff, Dr. Kaplan, Mr. Lind, and Ms. Truex, while noting Mr. Chan and Dr. Goldman will not stand for re-election, reducing board size from 9 to 7. Board leadership separated Chairman (Mr. Heffernan since March 2025) from CEO (Dr. Neil), with the board meeting 5 times in 2025 and all directors attending at least 75% of meetings. Committees (Audit, Compensation, Nominating and Corporate Governance) oversee key risks including financial, compensation, and cybersecurity.

• ·Record Date for Annual Meeting: April 6, 2026
• ·Annual Meeting Date and Time: June 2, 2026 at 8:30 a.m. Eastern Time (registration from 8:15 a.m.), virtual at www.virtualshareholdermeeting.com/AVTX2026
• ·Independent directors meet in executive session no fewer than twice per year
• ·Dr. Neil employed since February 2020, CEO since February 2022
• ·Mr. Heffernan appointed Chairman in March 2025

10-04-2026

Spyre Therapeutics, Inc. (SYRE) filed a definitive proxy statement (DEF 14A) on April 10, 2026, for its 2026 Annual Meeting of Stockholders on May 27, 2026, to elect three Class I directors until 2029, approve executive compensation on a non-binding advisory basis, ratify KPMG LLP as independent auditor for the year ending December 31, 2026, and approve the amended and restated 2016 Employee Stock Purchase Plan. The record date is April 2, 2026, with 78,784,358 shares of common stock outstanding; the meeting will be virtual only. No financial performance metrics or period-over-period comparisons are detailed in the filing.

• ·Annual Meeting virtual at www.virtualshareholdermeeting.com/SYRE2026, 12:00 p.m. ET, with backup physical location at 221 Crescent Street, Building 23, Suite 105, Waltham, MA 02453 if technical issues arise
• ·Proxy materials available at www.proxyvote.com; Annual Report for year ended December 31, 2025 also available there

10-04-2026

BrightSpring Health Services, Inc. will hold its virtual Annual Meeting of Stockholders on May 21, 2026, at 1:00 p.m. ET to elect three Class II directors to serve until the 2029 Annual Meeting, ratify KPMG LLP as independent registered public accounting firm for 2026, and approve named executive officer compensation on an advisory basis. The record date is March 30, 2026, with 193,167,731 shares of common stock outstanding. Stockholders of record can vote in advance via internet, telephone, or mail by 11:59 p.m. ET on May 20, 2026, or during the virtual meeting.

• ·Voting deadline: 11:59 p.m. ET, May 20, 2026 for advance proxies.
• ·Proposal 1 (director election) is plurality vote; Proposals 2 and 3 require majority of voting power present.
• ·Meeting access: www.proxydocs.com/BTSG (12-digit control number required).

10-04-2026

DuPont de Nemours, Inc. released its 2026 Proxy Statement for the May 21, 2026 annual meeting, highlighting 2025 financial performance with net sales of $6.8B and Operating EBITDA of $1.63B, but GAAP income from continuing operations of only $98M and GAAP EPS of $0.21, compared to adjusted EPS of $1.68. The agenda includes electing 11 directors (9 independent), advisory approval of executive compensation, auditor ratification, and approving a certificate amendment for a reverse stock split and authorized shares reduction. The company notes its transformational divestitures and separations, including the recent Qnity Electronics spin-off and Aramids divestiture.

• ·Annual meeting online at www.virtualshareholdermeeting.com/DD2026 on May 21, 2026 at 1:00 P.M. EDT; record date March 30, 2026.
• ·9 of 11 director nominees are independent.
• ·New reportable segments post-Electronics Separation: Healthcare & Water Technologies and Diversified Industrials.

10-04-2026

Aebi Schmidt Group's 2026 Proxy Statement discloses 2025 Pay Versus Performance data, showing Compensation Actually Paid (CAP) for PEO Barend Fruithof at $2,918,585 (up from SCT total of $2,848,741) and average Non-PEO NEO CAP at $1,007,872 (up from $891,139), linked to metrics like Operating EBIT at 5.9% of Net Sales and Net Income of $9.706M. However, company TSR declined to $93 from a $100 initial investment (July-Dec 2025), underperforming the peer group TSR of $120. Beneficial ownership as of record date shows major holders like PCS Holding AG (24.7%) and directors/execs group (39.1%), with total shares outstanding at 77,435,027.

• ·Annual General Meeting scheduled for May 21, 2026, at 10:00 a.m. CEST in Glattpark, Switzerland.
• ·All Section 16 filings timely except late Form 3s for PCS Holding AG, Gebuka AG, Marco Portmann, Martin Ritter, and Gerold Büttiker due to EDGAR Next delays.

10-04-2026

American Assets Trust, Inc., a REIT, filed its DEF 14A Proxy Statement on April 10, 2026, for the 2026 Annual Meeting of Stockholders on June 1, 2026, at 8:00 a.m. PDT in San Diego, CA. Shareholders will vote on electing five directors to serve until the next annual meeting, ratifying Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and an advisory vote to approve executive compensation. The record date for share ownership to vote is the close of business on March 27, 2026.

• ·Meeting location: Torrey Point, 3420 Carmel Mountain Road, Suite 100, San Diego, California 92121
• ·Proxy materials and 2025 Annual Report available online at https://materials.proxyvote.com/024013 starting April 10, 2026
• ·Company address: 3420 Carmel Mountain Road, Suite 100, San Diego, CA 92121; Phone: (858) 350-2600
• ·Fiscal year end: December 31
• ·Standard Industrial Classification: Real Estate Investment Trusts [6798]; State of Incorporation: MD

10-04-2026

Atlanticus Holdings Corporation issued its definitive proxy statement for the 2026 Annual Meeting of Shareholders on May 7, 2026, at 9:00 a.m. local time at its Atlanta headquarters, primarily to elect seven directors for terms expiring at the 2027 annual meeting. The record date is March 13, 2026, with 14,911,958 shares of common stock outstanding, entitling holders to one vote per share; no cumulative voting rights apply. The proxy materials include the 2025 Annual Report on Form 10-K, and shareholders are urged to submit proxies by May 6, 2026.

• ·Meeting location: Five Concourse Parkway, Suite 300, Atlanta, Georgia 30328
• ·Proxy submission deadline for record holders: 11:59 p.m. E.T. on May 6, 2026
• ·Includes 2025 Annual Report to Shareholders and Form 10-K for fiscal year ended December 31, 2025
• ·XBRL tags reference equity compensation disclosures for Principal Executive Officers (PEOs) and Non-PEO Named Executive Officers (NEOs) for fiscal years 2021-2025, but no specific values provided in filing excerpt

10-04-2026

Amalgamated Financial Corp. (AMAL) filed its DEF 14A proxy statement on April 10, 2026, providing executive compensation disclosures for principal executive officers including Priscilla Sims Brown, Keith Mestrich, and Lynne Fox. The filing covers fiscal years 2021 through 2025 and includes XBRL-tagged data on elements such as equity awards granted, changes in pension values, year-end fair values of equity awards, vesting date fair values, and dividends on unvested equity. No specific performance metrics or changes are detailed in the provided content.

• ·Filing covers compensation adjustments including aggregate change in pension value, pension adjustments for prior service cost, year-end fair value of equity awards granted in covered year outstanding and unvested, changes in fair value of outstanding and unvested equity awards granted in prior years, vesting-date fair value of equity awards granted and vested in covered year, and dividends or other earnings paid on equity awards not otherwise reflected in total compensation.

10-04-2026

Bentley Systems, Incorporated issued its definitive proxy statement (DEF 14A) on April 10, 2026, for the virtual Annual Meeting of Stockholders on May 21, 2026, at 11:00 a.m. ET via www.meetnow.global/BSY2026. Stockholders of record as of March 31, 2026, are eligible to vote on three proposals: election of director nominees, an advisory vote to approve named executive officer compensation, and ratification of KPMG LLP as the independent registered public accounting firm for 2026. Proxy materials and the annual report are available at www.envisionreports.com/BSY, with voting deadlines by 11:59 p.m. ET on May 20, 2026.

• ·Class A common stock entitled to 29 votes per share; Class B common stock entitled to 1 vote per share.
• ·Voting by Internet at www.envisionreports.com/BSY, telephone at 1-800-652-8683, or mail using enclosed proxy card.
• ·Quorum requires majority in voting power; Proposal 1 (directors) by plurality vote; Proposals 2 and 3 by majority of voting power present.

10-04-2026

NexPoint Residential Trust, Inc. (NXRT) filed its DEF 14A proxy statement on April 10, 2026, detailing corporate governance practices, board structure, and director compensation for the fiscal year ended December 31, 2025. The Board held five meetings with each director attending at least 75% of meetings, and all directors attended the 2025 annual stockholder meeting; non-management directors each hold 3,429 RSUs as of year-end. James Dondero serves as President and Chairman, with Scott Kavanaugh as lead independent director, and the Board affirmed independence for Edward Constantino, Scott Kavanaugh, Dr. Arthur Laffer, Dr. Swain, and Catherine Wood.

• ·Board adopted majority voting policy on February 13, 2019.
• ·Audit committee oversees risk assessment, including cybersecurity; nominating and corporate governance committee oversees ESG risks.
• ·All directors at the 2025 annual meeting attended the stockholder meeting.

10-04-2026

Redwire Corporation's definitive proxy statement for the 2026 Annual Meeting on May 20, 2026, at 10:00 a.m. ET (virtual only) solicits votes to elect three Class II directors (Reggie Brothers, Michael Greene, Dorothy D. Hayes) until the 2029 annual meeting, ratify KPMG LLP as independent auditors for the year ending December 31, 2026, approve named executive officer compensation on an advisory basis, and approve an annual frequency for future say-on-pay votes. The record date is March 27, 2026, with 198,918,728 shares of common stock and 46,505.1 shares of Series A convertible preferred stock outstanding, providing a total voting basis of 214,986,019 shares on an as-converted basis. No financial performance metrics or period-over-period comparisons are detailed in the provided filing content.

• ·Preferred Stock conversion price: $3.05 per share, yielding approximately 345.49 votes per share as of record date.
• ·Virtual meeting access: www.virtualshareholdermeeting.com/RDW2026; requires 16-digit control number.
• ·Board voting recommendations: FOR all director nominees, FOR auditor ratification, FOR NEO compensation approval, Every Year for say-on-pay frequency.
• ·Notice-and-access delivery method used; proxy materials available at www.proxyvote.com, https://ir.redwirespace.com, and SEC website.

10-04-2026

The Cheesecake Factory Incorporated's 2026 DEF 14A Proxy Statement seeks stockholder approval for the election of eight current director nominees at the annual meeting, ratification of the selection of the independent registered public accounting firm, and a non-binding advisory vote to approve executive compensation. The document details robust corporate governance practices, including director independence, board committee structures, risk oversight, and stockholder engagement, alongside comprehensive executive compensation programs emphasizing performance-based pay aligned with company performance. No specific financial metrics or period-over-period comparisons are provided in the filing excerpt.

• ·Proxy statement filed April 10, 2026.
• ·All eight director nominees are current directors.
• ·Director nominees possess extensive restaurant industry experience, including operational, leadership, and financial expertise.

10-04-2026

TWFG, Inc. reported strong FY2025 performance with total revenue increasing 22.0% to $248.5 million, driven by 11.6% organic growth across Insurance Services and MGA platforms. Net income rose 44% to $41.2 million (16.6% margin), and Adjusted EBITDA grew 47.4% to $66.8 million (26.9% margin), highlighting operating leverage and cash generation. The proxy statement seeks stockholder approval for electing six directors and ratifying Deloitte & Touche LLP as auditors for 2026 at the virtual annual meeting on May 27, 2026.

• ·Annual Meeting: May 27, 2026, 9:00 a.m. CT, virtual at www.virtualshareholdermeeting.com/TWFG2026
• ·Record date: March 30, 2026
• ·Proposals: Elect six directors (Richard F. ("Gordy") Bunch III, Michael Doak, Jonathan Anderson, Michelle Caroline Bunch, Robin A. Ferracone, Janet S. Wong); Ratify Deloitte & Touche LLP for FY2026
• ·Board: Six members, majority independent
• ·IPO completed July 2024

10-04-2026

J.Jill, Inc. issued its DEF 14A Proxy Statement for the virtual Annual Meeting of Stockholders on June 3, 2026, seeking approval to elect two Class III directors for three-year terms and ratify Grant Thornton as independent registered public accounting firm for the fiscal year ending January 30, 2027. The record date is April 6, 2026, with 14,906,245 shares of common stock outstanding entitled to vote. No financial performance metrics or compensation details are provided in the visible sections.

• ·Annual Meeting: June 3, 2026 at 8:30 AM Eastern, virtual-only via live audio webcast at https://edge.media-server.com/mmc/p/fcm59jfz (password: jjill2026).
• ·Fiscal Year 2025 ended January 31, 2026.
• ·Proxy materials available online on or about April 23, 2026.

10-04-2026

Seacoast Banking Corporation of Florida's 2026 definitive proxy statement for its May 20 annual meeting seeks shareholder approval for electing five Class III directors, declassifying the board, an advisory vote on named executive officer compensation, and ratifying Crowe LLP as auditors for fiscal 2026. The shareholder letter reports robust 2025 performance including 9% above-peer organic loan growth, 10% year-over-year net interest margin expansion, adjusted efficiency ratio improving over five points to 58%, and 45% growth in adjusted pre-tax pre-provision earnings, alongside completions of Villages Bancorporation and Heartland Bancshares acquisitions to bolster its Florida franchise. Strong capital position with 14.5% Tier 1 capital ratio and 78% loan-to-deposit ratio was maintained.

• ·Record date for voting eligibility: March 25, 2026
• ·Annual meeting location: Hutchinson Shores Resort, 3793 NE Ocean Blvd, Jensen Beach, FL 34957 at 10:00 a.m. ET
• ·Proposal 2: Amend Amended and Restated Articles of Incorporation to declassify the Board of Directors

10-04-2026

Octave Specialty Group completed a transformational year in 2025, selling its Legacy Financial Guarantee business to Oaktree for $420 million plus a $4.3 million adjustment and acquiring ArmadaCorp Capital for $250 million, with total revenue from continuing operations up 6.5% to $251 million and premium production rising 50% to $1,312 million driven by Insurance Distribution (+93% to $952 million). However, Specialty Property and Casualty premiums declined 6% to $360 million, Insurance Distribution reported a higher pre-tax loss of $23.1 million (vs. $8.2 million in 2024), and the STIP payout was 84% of target. The proxy seeks approval for director elections, advisory say-on-pay, auditor ratification, and the 2026 Incentive Compensation Plan at the May 28, 2026 virtual annual meeting.

• ·Annual Meeting on May 28, 2026 at 11:00 a.m. ET, virtual at www.virtualshareholdermeeting.com/OSG2026; Record Date April 2, 2026.
• ·74% ownership in Pivix following note conversion.
• ·Company repurchased shares at average price of $8.72.

10-04-2026

Royalty Pharma plc's 2026 Proxy Statement highlights strong 2025 performance, including returning over $1.7B to shareholders via $1.2B in share repurchases and deploying $2.6B on royalty acquisitions such as those with Revolution Medicines and BeOne Medicines on Imdelltra, alongside internalizing its operating platform. The Board added Carole Ho and Bess Weatherman, bringing expertise in biopharma and finance. The Annual General Meeting is scheduled for June 4, 2026, with proposals including election of nine directors, advisory votes on executive compensation and UK remuneration report, and ratification of Ernst & Young LLP as auditors.

• ·Annual General Meeting date: June 4, 2026, at 9:00 a.m. ET, 110 East 59th Street, New York, NY 10022
• ·Record date: April 6, 2026
• ·Proposals include ratification of Ernst & Young LLP as independent registered public accounting firm and UK statutory auditor, authorization for share allotments, and approval of share purchase agreements

10-04-2026

SiriusPoint Ltd's DEF 14A proxy statement for the 2026 Annual General Meeting on May 20, 2026 seeks shareholder approval for electing Susan L. Cross and Sabra R. Purtill as Class I directors, an advisory vote on named executive officer compensation, appointment of PricewaterhouseCoopers LLP as independent auditor, and approval of the SiriusPoint SharePlan. The Board comprises 11 directors (8 independent) with 98% attendance at 2025 meetings, and Franklin (Tad) Montross IV and Peter W. H. Tan are not standing for re-election. On March 16, 2026, the company announced a planned restructuring into four business areas: Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty.

• ·Annual General Meeting: May 20, 2026, 10:00 a.m. Atlantic Daylight Time, virtual webcast at https://meetnow.global/MAUQ2A2; record date March 30, 2026.
• ·Armada sold to Ambac Financial Group Inc. and deconsolidated as of November 1, 2025; underwriting partnership continues until end of 2030.
• ·Director retirement policy at age 75; policy limits excessive external board service.
• ·Prohibition on hedging and pledging by executives and directors; clawback policy for senior executives.

10-04-2026

Capricor Therapeutics, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders on June 4, 2026, seeking approval to elect eight directors for one-year terms, ratify Rose, Snyder & Jacobs LLP as independent auditors for FY 2026, approve executive compensation on an advisory basis, vote on the frequency of future say-on-pay votes (recommending one year), and amend the Certificate of Incorporation for officer exculpation. The record date is April 6, 2026, with 57,840,102 shares of common stock outstanding entitled to vote. No financial performance data or period comparisons are provided in the filing.

• ·Annual Meeting time: 10:00 a.m. PDT on June 4, 2026
• ·Annual Meeting location: 10865 Road to the Cure, Suite 150, San Diego, California 92121
• ·Proxy materials mailing date: on or about April 16, 2026
• ·Fiscal year for auditor ratification: ending December 31, 2026

10-04-2026

ClearPoint Neuro, Inc. filed its DEF 14A proxy statement dated April 10, 2026, for the virtual-only Annual Meeting of Stockholders on May 20, 2026, seeking approval to elect seven directors, ratify Cherry Bekaert LLP as independent auditors for the fiscal year ending December 31, 2026, approve executive compensation on an advisory basis, and approve the Seventh Amended and Restated 2013 Incentive Compensation Plan. The record date for voting is March 23, 2026. The company engaged Sodali & Co. for proxy solicitation at an estimated fee of $10,000 plus expenses.

• ·Annual Meeting held virtually at https://www.cstproxy.com/clearpointneuro/2026 at 10:00 a.m. Pacific Time
• ·Stockholders of record as of March 23, 2026 are entitled to vote
• ·Proxy materials available at https://www.cstproxy.com/clearpointneuro/2026